伊朗背景在卫生技术评估发展中的作用：挑战与解决方案。
The role of Iran's context for the development of health technology assessment: challenges and solutions.
作者信息
Behzadifar Meysam, Behzadifar Masoud, Saran Maryam, Shahabi Saeed, Bakhtiari Ahad, Azari Samad, Bragazzi Nicola Luigi
机构信息
Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
出版信息
Health Econ Rev. 2023 Apr 20;13(1):23. doi: 10.1186/s13561-023-00438-7.
Abstract
Health technology assessment (HTA) is a comprehensive and structured evaluation that aims to analyze the potential impacts of health technologies, including medical devices, diagnostic tools, pharmaceuticals, and public health interventions. Its purpose is to provide policymakers with evidence-based information to inform decisions related to the utilization and implementation of these technologies. HTA allows for the comparison of various scenarios related to a technology across a wide range of factors. This can aid in the creation of an essential drug list and health benefits package that is tailored to the actual needs of the community within a given healthcare system. In the present paper, we review the role of Iran's context for the development of HTA, in terms of challenges and solutions.
摘要
卫生技术评估（HTA）是一项全面且结构化的评估，旨在分析卫生技术的潜在影响，包括医疗设备、诊断工具、药品以及公共卫生干预措施。其目的是为政策制定者提供基于证据的信息，以便为与这些技术的使用和实施相关的决策提供参考。HTA允许在广泛的因素范围内比较与一项技术相关的各种情景。这有助于制定符合特定医疗体系内社区实际需求的基本药物清单和健康福利套餐。在本文中，我们从挑战和解决方案的角度审视了伊朗的背景情况对HTA发展的作用。
相似文献
1
The role of Iran's context for the development of health technology assessment: challenges and solutions.
Health Econ Rev. 2023 Apr 20;13(1):23. doi: 10.1186/s13561-023-00438-7.
2
Research gaps identified in Iran's health technology assessment reports.
Health Res Policy Syst. 2023 Dec 11;21(1):132. doi: 10.1186/s12961-023-01043-0.
3
Health technology assessment in Iran: challenges and views.
Med J Islam Repub Iran. 2014 Dec 29;28:157. eCollection 2014.
4
Health technology assessment of medical devices: What is different? An overview of three European projects.
Z Evid Fortbild Qual Gesundhwes. 2015;109(4-5):309-18. doi: 10.1016/j.zefq.2015.06.011. Epub 2015 Jul 26.
5
Assessing the Factors Associated With Iran's Intra-Industry Trade in Pharmaceuticals.
Glob J Health Sci. 2015 Mar 30;7(5):311-9. doi: 10.5539/gjhs.v7n5p311.
6
History of primary health care in Iran.
J Prev Med Hyg. 2023 Nov 1;64(3):E367-E374. doi: 10.15167/2421-4248/jpmh2023.64.3.3081. eCollection 2023 Sep.
7
Identifying the Challenges of Iran's Health Houses and Presenting a Solution.
Electron Physician. 2016 Oct 25;8(10):3122-3126. doi: 10.19082/3122. eCollection 2016 Oct.
8
2012-2025 Roadmap of I.R.Iran's Disaster Health Management.
PLoS Curr. 2012 Jul 16;4:e4f93005fbcb34. doi: 10.1371/4f93005fbcb34.
9
Policy Analysis Of Iranian Pharmaceutical Sector; A Qualitative Study.
Risk Manag Healthc Policy. 2019 Nov 7;12:199-208. doi: 10.2147/RMHP.S209318. eCollection 2019.
10
Role of nongovernmental organizations in Iran's health system: What do they do and what can they do?
J Educ Health Promot. 2022 Mar 23;11:101. doi: 10.4103/jehp.jehp_584_21. eCollection 2022.
引用本文的文献
1
Challenges in adopting health technology assessment for evidence-based policy in Iran: a qualitative study.
J Health Popul Nutr. 2025 Apr 23;44(1):134. doi: 10.1186/s41043-025-00887-2.
2
Navigating barriers to health technology assessment development in Iran: a qualitative exploration of stakeholder perspectives.
Arch Public Health. 2025 Mar 27;83(1):83. doi: 10.1186/s13690-025-01566-8.
3
Policy brief: addressing the shortage of human resources in the Iranian health system.
J Prev Med Hyg. 2025 Jan 31;65(4):E586-E593. doi: 10.15167/2421-4248/jpmh2024.65.4.3459. eCollection 2024 Dec.
4
Assessing the development of health technology assessment in Iran: a policy analysis using Kingdon's Multiple streams framework: a qualitative study.
BMC Public Health. 2025 Jan 20;25(1):226. doi: 10.1186/s12889-025-21465-5.
5
Barriers and challenges of establishing family physician policy for urban population; evidence from a qualitative study in Iran.
J Prev Med Hyg. 2024 Oct 31;65(3):E434-E441. doi: 10.15167/2421-4248/jpmh2024.65.3.3346. eCollection 2024 Sep.
6
Fragmentation of payment systems: an in-depth qualitative study of stakeholders' experiences with the neonatal intensive care payment system in Iran.
Health Econ Rev. 2024 Oct 10;14(1):85. doi: 10.1186/s13561-024-00564-w.
7
Unleashing the potential: the imperative of political support for health technology assessment in Iran.
Health Econ Rev. 2024 Oct 8;14(1):84. doi: 10.1186/s13561-024-00563-x.
8
Challenges in institutionalizing evidence-informed priority setting for health service packages: a qualitative document and interview analysis from Iran.
Health Res Policy Syst. 2024 Aug 19;22(1):110. doi: 10.1186/s12961-024-01207-6.
9
Research gaps identified in Iran's health technology assessment reports.
Health Res Policy Syst. 2023 Dec 11;21(1):132. doi: 10.1186/s12961-023-01043-0.
10
Development and validation of primary health care quality assessment tool.
BMC Health Serv Res. 2023 Oct 26;23(1):1156. doi: 10.1186/s12913-023-10162-x.
本文引用的文献
1
Hepatitis B vaccination in Iran: Historical policies and programs.
J Prev Med Hyg. 2022 Dec 31;63(4):E618-E624. doi: 10.15167/2421-4248/jpmh2022.63.4.2731. eCollection 2022 Dec.
2
Iranian primary health care network: challenges and ways forward.
Prim Health Care Res Dev. 2023 Jan 9;24:e1. doi: 10.1017/S1463423622000354.
3
Developing Iranian sub-national Primary Health Care Measurement Framework: a study protocol.
Prim Health Care Res Dev. 2022 Oct 11;23:e62. doi: 10.1017/S1463423622000469.
4
Inequality in households' access to primary health care (PHC): a case study in Kerman, southeast Iran.
BMC Health Serv Res. 2022 Aug 23;22(1):1077. doi: 10.1186/s12913-022-08467-4.
5
How Least Developed to Lower-Middle Income Countries Use Health Technology Assessment: A Scoping Review.
Pathog Glob Health. 2023 Mar;117(2):104-119. doi: 10.1080/20477724.2022.2106108. Epub 2022 Aug 10.
6
Health Technology Assessment in Support of National Health Insurance in South Africa.
Int J Technol Assess Health Care. 2022 May 6;38(1):e44. doi: 10.1017/S0266462322000265.
7
Financial Protection Indexes and the Iranian Health Transformation Plan: A Systematic Review.
Yale J Biol Med. 2021 Sep 30;94(3):465-476. eCollection 2021 Sep.
8
Health Technology Assessment in High, Middle, and Low-income Countries: New Systematic and Interdisciplinary Approach For Sound Informed-policy Making: Research Protocole.
Risk Manag Healthc Policy. 2021 Jun 28;14:2757-2770. doi: 10.2147/RMHP.S310215. eCollection 2021.
9
Health technology assessment in sub-Saharan Africa: a descriptive analysis and narrative synthesis.
Cost Eff Resour Alloc. 2021 Jul 7;19(1):39. doi: 10.1186/s12962-021-00293-5.
10
Addressing Challenges in Health Technology Assessment Institutionalization for Furtherance of Universal Health Coverage Through South-South Knowledge Exchange: Lessons From Bhutan, Kenya, Thailand, and Zambia.
Value Health Reg Issues. 2021 May;24:187-192. doi: 10.1016/j.vhri.2020.12.011. Epub 2021 Apr 7.
Zotero 插件